General form of registration statement for all companies including face-amount certificate companies

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.24.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Cash Flows From Operating Activities        
Net Loss $ (18,708,007) $ (16,983,981) $ (38,726,259) $ (20,324,648)
Stock-based compensation:        
Shares issued for services 60,624 270,967 331,591 2,148,889
Amortization of stock options and restricted stock units 1,692,725 2,002,980 2,633,826 2,852,309
Amortization of intangibles 83,015 71,396 109,004 109,947
Bad debt expense - related parties     300,000
Gain on settlement of liabilities, net     (926,829)
Loss on extinguishment of convertible note payable     9,737
Loss on IP R&D asset impairment 9,063,000 3,342,084  
Loss on goodwill impairment 18,872,850 33,547,278
Change in fair value of derivative liabilities (69,776) (14,167,560) (15,144,986) 4,677,388
Change in fair value of accrued issuable equity     9,405
Deferred tax benefit (2,345,025) (942,749) (24,803)
Offering costs allocated to warrant liabilities     604,118
Changes in operating assets and liabilities:        
Prepaid expenses and other current assets 1,273,033 36,340 1,018,303 (1,377,247)
Accounts payable (99,169) 428,632 1,214,599 (5,515,042)
Accounts payable – related parties 51,227 (215,495)
Accrued expenses 94,778 127,449 319,936 (1,210,076)
Accrued expenses – related parties 141,366 140,097 169,788 (436,581)
Total adjustments 9,945,798 7,783,151 26,598,674 953,220
Net Cash Used In Operating Activities (8,762,209) (9,200,830) (12,127,585) (19,371,428)
Accrued issuable equity     (52,500)
Cash Flows From Financing Activities        
Proceeds from sale of July 2022 Offering stock and warrants 6,499,737 6,499,737
Proceeds from sale of December 2022 common stock and common stock warrants     5,999,851
Proceeds from sale of April 2023 Offering stock and warrants 2,999,882    
Proceeds from sale of August 2023 Offering stock and warrants 2,999,606    
Proceeds from exercise of July 2022 Offering pre-funded warrants 155    
Proceeds from exercise of April 2023 Offering pre-funded warrants 117 263
Proceeds from exercise of December 2022 pre-funded warrants     150
Proceeds from exercise of August 2023 Offering pre-funded warrants 66    
Payment of offering costs in connection with July 2022 Offering stock and warrants (529,982)    
Payment of offering costs in connection with April 2023 Offering stock and warrants (279,994)    
Payment of offering costs in connection with August 2023 Offering stock and warrants (294,976)    
Shares issued for cash, net of issuance costs     26,666,200
Offering costs in connection with 2021 sale of stock and warrants     (2,055,130)
Offering costs in connection with July 2022 sale of common stock and common stock warrants     (529,982)
Offering costs in connection with December 2022 sale of common stock and common stock warrants     (484,991)
Proceeds from loans payable     1,060,890 1,618,443
Repayment of convertible debt – related parties     (10,000)
Repayment of loans payable, net of adjustments (Note 9)     (1,591,035) (375,789)
Repayment of loans payable (985,175) (1,491,986) (81,277) (431,805)
Net Cash Provided By Financing Activities 4,439,526 4,477,924 10,873,606 25,411,919
Effect of Exchange Rate Changes on Cash 15,093 87,037 (419) 75,473
Net (Decrease) Increase In Cash (4,307,590) (4,635,869) (1,254,398) 6,115,964
Cash - Beginning of Period 6,970,110 8,224,508 8,224,508 2,108,544
Cash - End of Period 2,662,520 3,588,639 6,970,110 8,224,508
Supplemental Disclosures of Cash Flow Information:        
Cash paid during the period for income taxes
Cash paid during the period for interest expense $ 21,722 $ 13,423 15,060 35,351
Non-cash investing and financing activities:        
Common stock issued upon conversion of KBL debt     1,931,388
Common stock issued upon conversion of 180 debt     432,383
Common stock issued in connection with repayment of related party loans and convertible notes     851,112
Shares and warrants issued for Alpha Settlement     1,013,331
Exchange of common stock equivalents for common stock     146
Shares issued to settle accounts payable     1,750,000
Reclassification of accrued issuable equity     $ 43,095